ArticleJournal of anesthesia2026
Effect of IoC2-guided analgesic titration on intraoperative opioid consumption in older patients undergoing laparoscopic colorectal surgery: a randomized controlled trial.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Reply to comments on IoC2-guided analgesic titration.Journal of anesthesia · 2026Article
- In reply: interpreting an IoC2-guided analgesic titration protocol.Journal of anesthesia · 2026Article
- Comment on "Effect of IoC2-guided analgesic titration on intraoperative opioid consumption in older patients undergoing laparoscopic colorectal surgery: a randomized controlled trial".Journal of anesthesia · 2026Article
- Comment on "Effect of IoC2-guided analgesic titration on intraoperative opioid consumption in older patients undergoing laparoscopic colorectal surgery: a randomized controlled trial".Journal of anesthesia · 2026Article
- Overlapping IoC2 trajectories and interpretive considerations.Journal of anesthesia · 2026Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
purposeHemodynamic variables may be unreliable indicators of intraoperative nociception in older patients. We evaluated whether a prespecified IoC2-based sufentanil dosing protocol reduces intraoperative sufentanil use compared with conventional hemodynamic guidance in older patients undergoing laparoscopic colorectal surgery.
methodsIn this prospective, single-center, parallel-group, single-blind randomized trial, patients aged 65-90 years with ASA physical status II-III undergoing elective laparoscopic colorectal resection were randomized 1:1 to IoC2-guided or hemodynamic-guided analgesia. Anesthesia, antiemetic prophylaxis, neuromuscular blockade, and postoperative analgesia were standardized. The prespecified primary outcome was weight- and time-normalized intraoperative sufentanil consumption (μg/kg/h); total intraoperative sufentanil dose was also reported. The secondary outcomes included postoperative pain and sufentanil consumption, interleukin-6 concentrations, intraoperative hemodynamic safety events, vasoactive drug use, recovery outcomes, postoperative nausea and vomiting (PONV), and delirium.
resultsFifty-eight patients were analyzed (IoC2, n = 28; control, n = 30). The prespecified primary endpoint, weight- and time-normalized intraoperative sufentanil consumption, was lower with the prespecified IoC2-based protocol than with hemodynamic guidance (median [IQR], 0.10 [0.09-0.13] vs 0.17 [0.14-0.22] μg/kg/h; p < 0.001). Total intraoperative sufentanil dose was also lower in the IoC2 group (20.0 [16.9-26.3] vs 36.0 [27.8-44.4] μg; p < 0.001). Postoperative pain scores and sufentanil requirements were similar between groups, with no significant differences in hypotension, bradycardia, vasoactive drug use, baseline-adjusted interleukin-6 concentrations, or delirium. PACU PONV was less frequent in the IoC2 group (3.6% vs 30.0%; p = 0.012).
conclusionA prespecified IoC2-based sufentanil dosing protocol reduced weight- and time-normalized intraoperative sufentanil consumption without worsening early postoperative pain outcomes in older patients undergoing laparoscopic colorectal surgery. This finding should be interpreted as the effect of the tested dosing protocol rather than validation of the IoC2 target range or treatment threshold. The lower PACU PONV incidence was a secondary finding and requires confirmation in larger trials.
Indexed as
Identifiers
42479133What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.